A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Alterome Therapeutics, Inc.
Xencor, Inc.
Pfizer
A2 Biotherapeutics Inc.
Mirati Therapeutics Inc.
Arvinas Inc.
ALX Oncology Inc.
MBrace Therapeutics
Pheon Therapeutics
Pheon Therapeutics
Seagen Inc.
EXoPERT
Orano Med LLC
Eli Lilly and Company
Novartis
Var2 Pharmaceuticals
Takeda
NantCell, Inc.
AstraZeneca
Revolution Medicines, Inc.
Tempus AI
Massive Bio, Inc.
Eli Lilly and Company
Chongqing Precision Biotech Co., Ltd
HUYABIO International, LLC.
HUYABIO International, LLC.
Travera Inc
A2 Biotherapeutics Inc.
Elicio Therapeutics
Revolution Medicines, Inc.
Palleon Pharmaceuticals, Inc.
Alaunos Therapeutics
Novita Pharmaceuticals, Inc.
Gene Solutions
Turning Point Therapeutics, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Hoffmann-La Roche
Compugen Ltd
Tempus AI
Mirati Therapeutics Inc.
Intensity Therapeutics, Inc.
Compugen Ltd
Eli Lilly and Company
Mirati Therapeutics Inc.
NextCure, Inc.
Revolution Medicines, Inc.